Ambrisentan Retains Its Pro‐Autophagic Activity on Human Pulmonary Artery Endothelial Cells Exposed to Hypoxia in an In Vitro Model Mimicking Diabetes
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70528 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Manuela Cabiati und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry and Molecular Biology, Institute of Clinical Physiology, CNR, Pisa, Italy. Hauptthemen laut MEDLINE: Endothelial Cells, Autophagy, Pulmonary Artery, Pyridazines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Cardiovascular comorbidities are associated with reduced treatment response in group 1 pulmonary arterial hypertension (PAH). This may result from misdiagnosis of group 2 PH, but it can also be explained as the loss of ability of pulmonary endothelial cells to respond to specific antiremodeling drugs. We evaluated the effects of high glucose (HG) and hyperosmolar stress (high mannitol, HM) on the response of human pulmonary artery endothelial cells (hPAECs) to ambrisentan (AMB), focusing on autophagy, viability, apoptosis and several microRNAs involved in pulmonary arterial remodelling. hPAECs were incubated with 30.5 mM HG or 25 mM HM, with/without 0.02 nM AMB in normoxia (Nx) or hypoxia (Hx) for 24 h. Hx reduced cell survival ( p = 0.03) and autophagy ( p = 0.02), an effect mimicked by HG and HM only in Nx. In Nx and Hx, AMB reverted the effect of HG, but not HM on autophagy, almost completely or partially, respectively. Compared to Nx, Hx increased the antiapoptotic miR124‐3p in vehicle‐treated hPAEC ( p = 0.002), and induced an opposite effect on antiapoptotic and proliferative miR191‐3p. In Nx, AMB induced miR124‐3p in HG‐ ( p = 0.04 vs. HG+A_Nx) and HM‐treated ( p < 0.0001 vs. HM+AMB_Nx) hPAECs, and miR191‐3p in HM‐treated hPAECs ( p = 0.03). In H, A induced a similar effect on miR124‐3p in hPAEC exposed to AMB+HM ( p = 0.02). In hPAEC exposed to Hx, AMB retains its pro‐autophagic effects in an in vitro model mimicking diabetes. miR124‐3p and, to a lesser extent, miR191‐3p may act as biomarkers of disease and treatment response to specific drugs in patients with PAH and diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biochemistry and Molecular Biology, Institute of Clinical Physiology, CNR, Pisa, Italy.
- Department of Pathology, Cardiology Division, University of Pisa, Pisa, Italy.
- Department of Pathology, Laboratory of Biochemistry, University of Pisa, Pisa, Italy.
- Unit of Translational Critical Care Medicine, Laboratory of Basic and Applied Medical Sciences, Interdisciplinary Research Center "Health Science," Scuola Superiore Sant'Anna, Pisa, Italy.
ORCID-Profile: Rosalinda Madonna
Förderung
- Ministero dell'Università e della Ricerca
Zitieren
APA
Cabiati, M., Biondi, F., Ghelardoni, S., Casieri, V., Lionetti, V., Sgalippa, A., Del Ry, S., & Madonna, R. (2025). Ambrisentan Retains Its Pro‐Autophagic Activity on Human Pulmonary Artery Endothelial Cells Exposed to Hypoxia in an In Vitro Model Mimicking Diabetes. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70528
Vancouver
Cabiati M, Biondi F, Ghelardoni S, Casieri V, Lionetti V, Sgalippa A, et al. Ambrisentan Retains Its Pro‐Autophagic Activity on Human Pulmonary Artery Endothelial Cells Exposed to Hypoxia in an In Vitro Model Mimicking Diabetes. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70528
BibTeX
@article{Cabiati2025,
author = {Cabiati, Manuela and Biondi, Filippo and Ghelardoni, Sandra and Casieri, Valentina and Lionetti, Vincenzo and Sgalippa, Agnese and Del Ry, Silvia and Madonna, Rosalinda},
title = {Ambrisentan Retains Its Pro‐Autophagic Activity on Human Pulmonary Artery Endothelial Cells Exposed to Hypoxia in an In Vitro Model Mimicking Diabetes},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70528}
}
EUVIMED